1-16 of 16
Elke Pogge von Strandmann
Close
Sort by
Journal Articles

Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma

Amit Sud, Hauke Thomsen, Giulia Orlando, Asta Försti, Philip J. Law, Peter Broderick, Rosie Cooke, Fadi Hariri, Tomi Pastinen, Douglas F. Easton, Paul D. P. Pharoah, Alison M. Dunning, Julian Peto, Federico Canzian, Rosalind Eeles, ZSofia Kote-Jarai, Kenneth Muir, Nora Pashayan, Daniele Campa, the PRACTICAL Consortium, Per Hoffmann, Markus M. Nöthen, Karl-Heinz Jöckel, Elke Pogge von Strandmann, Anthony J. Swerdlow, Andreas Engert, Nick Orr, Kari Hemminki, Richard S. Houlston
Journal: Blood
Blood (2018) 132 (19): 2040–2052.
https://doi.org/10.1182/blood-2018-06-855296
Published: 2018
Includes: Supplemental data
Journal Articles

A phase 1 study of the bispecific anti-CD30/CD16A antibody construct AFM13 in patients with relapsed or refractory Hodgkin lymphoma

Clinical Trials & Observations
Achim Rothe, Stephanie Sasse, Max S. Topp, Dennis A. Eichenauer, Horst Hummel, Katrin S. Reiners, Markus Dietlein, Georg Kuhnert, Joerg Kessler, Carolin Buerkle, Miroslav Ravic, Stefan Knackmuss, Jens-Peter Marschner, Elke Pogge von Strandmann, Peter Borchmann, Andreas Engert
Journal: Blood
Blood (2015) 125 (26): 4024–4031.
https://doi.org/10.1182/blood-2014-12-614636
Published: 2015
Journal Articles

Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-tumor activity

Katrin S. Reiners, Daniela Topolar, Alexander Henke, Venkateswara R. Simhadri, Jörg Kessler, Maike Sauer, Martina Bessler, Hinrich P. Hansen, Samir Tawadros, Marco Herling, Martin Krönke, Michael Hallek, Elke Pogge von Strandmann
Journal: Blood
Blood (2013) 121 (18): 3658–3665.
https://doi.org/10.1182/blood-2013-01-476606
Published: 2013
Includes: Supplemental data
Journal Articles

Galectin-1 serum levels reflect tumor burden and adverse clinical features in classical Hodgkin lymphoma

Brief Report
Jing Ouyang, Annette Plütschow, Elke Pogge von Strandmann, Katrin S. Reiners, Sabine Ponader, Gabriel A. Rabinovich, Donna Neuberg, Andreas Engert, Margaret A. Shipp
Journal: Blood
Blood (2013) 121 (17): 3431–3433.
https://doi.org/10.1182/blood-2012-12-474569
Published: 2013
Journal Articles

Delayed development of chronic lymphocytic leukemia in the absence of macrophage migration inhibitory factor

Nina Reinart, Phuong-Hien Nguyen, Jorge Boucas, Natascha Rosen, Hans-Michael Kvasnicka, Lukas Heukamp, Cornelia Rudolph, Vangica Ristovska, Tanja Velmans, Carolin Mueller, Katrin S. Reiners, Elke Pogge von Strandmann, Günter Krause, Manuel Montesinos-Rongen, Brigitte Schlegelberger, Marco Herling, Michael Hallek, Günter Fingerle-Rowson
Journal: Blood
Blood (2013) 121 (5): 812–821.
https://doi.org/10.1182/blood-2012-05-431452
Published: 2013
Includes: Supplemental data
Journal Articles

A Phase I Study with the Bispecific Anti-CD30 × Anti-CD16A Antibody Construct AFM13 in Patients with Relapsed or Refractory Hodgkin Lymphoma,

Achim Rothe, MD, Anas Younes, MD, Katrin S. Reiners, PhD, Markus Dietlein, MD, Dennis A. Eichenauer, MD, Joerg Kessler, Max S. Topp, MD, Horst Hummel, MD, Miroslav Ravic, MD, PhD, Christian Hucke, PhD, Elke Pogge von Strandmann, PhD, Andreas Engert, MD
Journal: Blood
Blood (2011) 118 (21): 3709.
https://doi.org/10.1182/blood.V118.21.3709.3709
Published: 2011
Journal Articles

NK Cells in Hodgkin Lymphoma Are Impaired but Can Be Activated

Joerg Kessler, Katrin S. Reiners, PhD, Maike Sauer, Andreas Engert, MD, Elke Pogge von Strandmann, PhD
Journal: Blood
Blood (2011) 118 (21): 2182.
https://doi.org/10.1182/blood.V118.21.2182.2182
Published: 2011
Journal Articles

A Bispecific Protein Targeting the NKG2D Receptor on Natural Killer Cells: In Vitro and In Vivo activity of ULBP2-CEA

Marie Madlener, Achim Rothe, MD, Ron Jachimowicz, Katrin S. Reiners, PhD, Sampurna Chatterjee, Roland Ullrich, MD, Paul Yazaki, PhD, Andreas Engert, MD, Elke Pogge von Strandmann, PhD
Journal: Blood
Blood (2010) 116 (21): 2095.
https://doi.org/10.1182/blood.V116.21.2095.2095
Published: 2010
Journal Articles

Anti-EGFR Antibody Cetuximab in Refractory or Relapsed Multiple Myeloma: Preliminary Results and Evaluation of Response Prediction in a Phase II Clinical Trial

Bastian von Tresckow, M.D., Denissa Peine, Boris Böll, M.D., Dennis A Eichenauer, M.D., Elke Pogge von Strandmann, Ph.D., Stefan Knop, M.D., Marielle Goebeler, M.D., Michael Hallek, MD, Andreas Engert, M.D., Kai Hübel, M.D.
Journal: Blood
Blood (2008) 112 (11): 3686.
https://doi.org/10.1182/blood.V112.11.3686.3686
Published: 2008
Journal Articles

Prenylation Inhibitors as Potential Therapeutic Drugs in Hodgkin Lymphoma.

Bastian von Tresckow, MD, Peer Langendorf, Elke Pogge von Strandmann, PhD, Stefanie Sasse, MD, Samir Tawadros, Andreas Engert, MD, Hinrich P. Hansen, PhD
Journal: Blood
Blood (2006) 108 (11): 2513.
https://doi.org/10.1182/blood.V108.11.2513.2513
Published: 2006
Journal Articles

Mistargeting of Normal Cells in Anti-CD30 Immunotherapy of Lymphoma Cells Is Blocked by Selective Metalloproteinase Inhibitor.

Vijaya L. Simhadri, Elke Pogge von Strandmann, PhD, Dennis A. Eichenhauer, Andreas Ludwig, PhD, Katrin S. Reiners, PhD, Andreas Engert, PhD, Hinrich P. Hansen, PhD
Journal: Blood
Blood (2006) 108 (11): 2518.
https://doi.org/10.1182/blood.V108.11.2518.2518
Published: 2006
Journal Articles

Selection of Human Anti-CD22 scFvs from an Acute Lymphocytic Leukemia Related scFv Library with Ribosome Display.

Achim Rothe, MD, Ralf J. Hosse, PHD, Anne Nathanielsz, RA, Frank Oberhaeuser, RA, Elke Pogge von Strandmann, PHD, Andreas Engert, MD, Peter J. Hudson, PHD, Barbara E. Power
Journal: Blood
Blood (2006) 108 (11): 4527.
https://doi.org/10.1182/blood.V108.11.4527.4527
Published: 2006
Journal Articles

Tumor Cell-Derived HLA-B-Associated Transkript 3 (BAT3) Is a Ligand for NKp30 and Activates NK Cells.

Elke Pogge von Strandmann, PhD, Venkateswara R. Simhadri, Bastian von Tresckow, MD, Stefanie Sasse, MD, Katrin S. Reiners, PhD, Hinrich P. Hansen, PhD, Achim Rothe, MD, Peter Borchmann, MD, Peter J. McKinnon, PhD, Michael Hallek, Andreas Engert
Journal: Blood
Blood (2006) 108 (11): 643.
https://doi.org/10.1182/blood.V108.11.643.643
Published: 2006
Journal Articles

A novel bispecific protein (ULBP2-BB4) targeting the NKG2D receptor on natural killer (NK) cells and CD138 activates NK cells and has potent antitumor activity against human multiple myeloma in vitro and in vivo

Elke Pogge von Strandmann, Hinrich P. Hansen, Katrin S. Reiners, Roland Schnell, Peter Borchmann, Sabine Merkert, Venkateswara R. Simhadri, Andreas Draube, Marcel Reiser, Ingvill Purr, Michael Hallek, Andreas Engert
Journal: Blood
Blood (2006) 107 (5): 1955–1962.
https://doi.org/10.1182/blood-2005-05-2177
Published: 2006
Journal Articles

Engaging the NKG2D Receptor with a Novel Bispecific Protein (ULBP2-antiCD138) Activates NK Cells and Has Potent Antitumor Activity Against Human Multiple Myeloma.

Elke Pogge von Strandmann, PhD, Michael Hallek, MD, Andreas Engert, MD
Journal: Blood
Blood (2005) 106 (11): 5157.
https://doi.org/10.1182/blood.V106.11.5157.5157
Published: 2005
Journal Articles

The fully human anti-CD30 antibody 5F11 activates NF-κB and sensitizes lymphoma cells to bortezomib-induced apoptosis

Brief Report
Boris Böll, Hinrich Hansen, Friederike Heuck, Katrin Reiners, Peter Borchmann, Achim Rothe, Andreas Engert, Elke Pogge von Strandmann
Journal: Blood
Blood (2005) 106 (5): 1839–1842.
https://doi.org/10.1182/blood-2005-01-0427
Published: 2005